Navigation Links
Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations
Date:7/8/2008

been developed to overcome some of these issues."

"Prof. Beglinger's study provides yet further evidence in the application of our Eligen(R) technology as a potential solution to critical hurdles in pharmaceutical development. Hopefully, its use with GLP-1 in the treatment of diabetes will improve healthcare for millions of patients," said Michael V. Novinski, President and Chief Executive Officer of Emisphere.

Emisphere's Eligen(R) technology is based on the development of small organic molecules, termed delivery agents or carriers, that interact non-covalently with macromolecules to enable their oral absorption. GLP-1 is rapidly absorbed after oral administration with SNAC. Emisphere announced on June 23, 2008 that it entered a Development and License Agreement with Novo Nordisk A/S focused on the development of oral formulations of Novo Nordisk's proprietary GLP-1 receptor agonists.

ABOUT EMISPHERE TECHNOLOGIES, INC.

Emisphere Technologies, Inc. is a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules and pharmaceutical compounds using its Eligen(R) Technology. Some of these molecules or compounds can only be given by injection; when combined with our technology; convenient oral versions may be safe, effective and provide significant advantages. The benefits of other compounds are limited due to poor bioavailability, slow on-set of action or variable absorption. In those cases, use of Emisphere's technology can improve the therapeutic effectiveness of the compounds. The Eligen(R) technology can be applied to the oral route of administration as well other delivery pathways. The Web site is: http://www.emisphere.com.

Safe Harbor Statement Regarding Forward-looking Statements

The statements in this release and oral statements made by representatives of Emisphere relating to matters that are not historical facts (including witho
'/>"/>

SOURCE Emisphere Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
3. Emisphere Technologies Announces Positive Results From Animal Studies on Oral B12 Using eligen(R) Technology
4. Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen(R) Technology at Lower Doses
5. Proof of Concept Study in Second Species Demonstrates Increase in Absorption of Oral B12 Using Emisphere Technology
6. Emisphere Technologies Announces the Launch of a Human Clinical Trial For Oral Parathyroid Hormone (PTH)
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... August 28, 2014 The ... diagnostics Market (products, applications, techniques, end users and ... and Forecast, 2013 - 2020," indicates that the ... by 2020 registering a CAGR of 9.8% from ... diagnosis and cost effectiveness over alternative diagnostic techniques ...
(Date:8/28/2014)... , Aug. 28, 2014  Seres Health, ... diseases related to the human microbiome, announced today ... Vice President of R&D and Chief Scientific Officer, ... on Antimicrobial Agents and Chemotherapy (ICAAC). The presentation ... SER-109, a novel mixture of bacterial spores derived ...
(Date:8/28/2014)... , Aug. 28, 2014 /PRNewswire-iReach/ -- Gateway Analytical ... the 9 th Annual Global Pharma Manufacturing ... September 8-9 th . The Global Pharma Manufacturing ... in small molecule and biologic pharmaceutical manufacturing. The ... that today,s manufacturers face, such as the increasing ...
Breaking Medicine Technology:DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 3Seres Health to Present Clinical Findings at ICAAC 2014 Conference 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 3
... "Dr. Siegal,s Cookie Diet" Were the Top Two AOL ... McCain" Rounded Out the Top 5, MCLEAN, Va., ... of Dr. Siegal,s COOKIE DIET(R),hunger-controlling foods, today announced that ... named Sarah Palin his running mate, "Dr. Siegal,s,Cookie Diet" ...
... Sept. 5 The Florida,Technology, Research and ... Dr. Herbert Weissbach, distinguished,professor and director of ... the Charles E. Schmidt College of Science, ... of the State University Research,Commercialization Assistance Grant ...
Cached Medicine Technology:Sarah Palin, Dr. Siegal's Cookie Diet, and John McCain Top AOL Hot Searches List on August 29th 2Major State Grant Accelerates Research and Development of Novel Cancer Therapy 2Major State Grant Accelerates Research and Development of Novel Cancer Therapy 3
(Date:8/29/2014)... Botanica Day Spa recently announced the ... menu along with a special introductory offer for the ... uses small glass cups to create a suctioning of ... a comfortable but effective pressure. The cups are then ... engage more tissue. In contrast, traditional massage primarily uses ...
(Date:8/29/2014)... August 29, 2014 Edvance360, a leading ... tools for online teaching, as well as 2011 winner ... or Learning Management System, announced that their CTO, Brian ... in the ALS Ice Bucket Challenge on behalf of ... Sanders, Edvance360 Co-Founder. , “We know that the options ...
(Date:8/29/2014)... Dallas, Texas (PRWEB) August 29, 2014 ... raw data into observable data, which are used ... are used in health and fitness devices to ... in sensing technology can assist in regular patient ... costs and provide improved treatment results. Sensors help ...
(Date:8/29/2014)... 2014: A new ESC journal on cardiovascular pharmacotherapy is ... Oxford University Press. , European Heart Journal ... special launch issue has been produced for ESC Congress ... journal,s website goes live in September. , Editor in ... the number one journal in the field of clinical ...
(Date:8/29/2014)... According to these recent findings, there has been ... cases in the last few years. Medical expert and Herpes ... infections and the symptoms that make it hard for patients ... people aren't aware of the exact symptoms of these ailments, ... increase in the number of cases over the years has ...
Breaking Medicine News(10 mins):Health News:Cupping Massage Now Available at Botanica Day Spa in Clearwater, FL 2Health News:Cupping Massage Now Available at Botanica Day Spa in Clearwater, FL 3Health News:Cupping Massage Now Available at Botanica Day Spa in Clearwater, FL 4Health News:Edvance360 Participates In the ALS Ice Bucket Challenge (#ALSicebucketchallenge) 2Health News:Mobile Health and Fitness Sensor Market Growing at 40.29% CAGR by 2018 Forecasts a New Report at ReportsnReports.com 2Health News:Mobile Health and Fitness Sensor Market Growing at 40.29% CAGR by 2018 Forecasts a New Report at ReportsnReports.com 3Health News:Mobile Health and Fitness Sensor Market Growing at 40.29% CAGR by 2018 Forecasts a New Report at ReportsnReports.com 4Health News:Mobile Health and Fitness Sensor Market Growing at 40.29% CAGR by 2018 Forecasts a New Report at ReportsnReports.com 5Health News:ESC launches journal on CV pharmacotherapy 2Health News:It was reported that the Number on PositiveSingles.dating increased about 20% in 2014 2
... ESA Biosciences, a Magellan,Biosciences company and leader in ... that James P. Whelan has joined the company ... clinical-diagnostics,business. Mr. Whelan comes to ESA from Laboratory ... president of managed care for LabCorp,s,esoteric business. Previously, ...
... Concrete Legislation in America to Protect Long-Term Care ... Residents in Over 30 Years, ... first of its kind in the nation and the most concrete,legislation to ... signed into law by Oklahoma Governor Brad Henry,on Tuesday, June 10 at ...
... Cincinnati Children,s Hospital Medical Center has revealed new clues into ... blood cancers known as mixed lineage leukemias (MLL) and how ... the June 9 issue of Cancer Cell. , "We document ... altered to form a particular type, or lineage, of leukemia ...
... explored the first fork in the developmental road, getting a ... build either an embryo or a placenta. , By manipulating ... that develops from a fertilized egg but is not yet ... McKnight Brain Institute and the Harvard Stem Cell Institute caused ...
... who are morning people function better on tests , , ... who are morning people tend to get better grades ... of North Texas researchers. , They had 824 undergraduate ... sleep habits and daytime functioning, and found that students ...
... Existing Investment in Passive, Proximity Badges; Provides Strong ... ... 9 Duke University Health System is,deploying a new advanced ... information systems access for its,14,000 clinical users while maintaining strong ...
Cached Medicine News:Health News:ESA Names James P. Whelan Vice President, Sales & Marketing, Clinical Diagnostic Products 2Health News:ESA Names James P. Whelan Vice President, Sales & Marketing, Clinical Diagnostic Products 3Health News:Nursing Home for Sex Offenders Becomes Law, a First in America 2Health News:Microenvironment a main driver of aggressive multi-lineage leukemia disease type 2Health News:Microenvironment a main driver of aggressive multi-lineage leukemia disease type 3Health News:Microenvironment a main driver of aggressive multi-lineage leukemia disease type 4Health News:Stem cell discovery sheds light on placenta development 2Health News:Stem cell discovery sheds light on placenta development 3Health News:College Night Owls Have Lower Grades 2Health News:Duke University Health System to Implement Clinically Optimized, Advanced Authentication Solution From Sentillion 2Health News:Duke University Health System to Implement Clinically Optimized, Advanced Authentication Solution From Sentillion 3
... quantitative microplate enzyme immunoassay that detects elevated levels ... small amounts of NMP22 protein in the urine. ... elevated in the urine of patients with bladder ... The use of the NMP22 protein has been ...
... cystometry and urethral pressure profilometry. The ... bladder to be filled while cystometry ... the catheter in the bladder for ... is standing or sitting. Supplied sterile ...
... for cystometry and urethral pressure profilometry. ... faster filling of the bladder and ... lumen catheter construction allows the bladder ... performed. Triple lumen catheter construction allows ...
... Compact desktop analyzer for fast point-of-care ... syndrome, deep vein thrombosis and/or pulmonary embolism. ... rooms. , ,When every minute counts, ... determination of troponin T, myoglobin, and D-Dimer ...
Medicine Products: